These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4146912)

  • 1. A comparative study of the absorption of xanthinol nicotinate from slow-release and plain tablets in man.
    Sharma PL; Garg SK; Sikka SC
    Int J Clin Pharmacol; 1973 Jul; 7(4):299-302. PubMed ID: 4146912
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effects of placebo and plain and slow-release tablets of xanthinol nicotinate on exercise tolerance in normal human subjects.
    Sharma PL
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):19-21. PubMed ID: 631966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinic acid plasma concentrations after ingestion of 1,3,4,6-tetranicotinoyl-fructo-furanose (tetranicotinoylfructose, nicofuranose).
    Salmi HA; Frey H
    Curr Ther Res Clin Exp; 1974 Jun; 16(6):669-74. PubMed ID: 4211148
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of liver cirrhosis. Studies on the hemodynamic effect of xanthinol nicotinate in liver cirrhosis].
    Assheuer J; Boldt I; Schulz D; Winkler C
    Fortschr Med; 1973 Sep; 91(27):1085-8. PubMed ID: 4746762
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacokinetic studies following oral administration of 3,7-dimethyl-1-(5-oxo-hexyl)xanthine- 14 C (BL 191- 14 C) in rats, dogs and man].
    Christ O; Gleixner K; Kellner HM; Müller R; Rupp W
    Arzneimittelforschung; 1972 Nov; 22(11):1933-7. PubMed ID: 4679068
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of xanthinol-nicotinate on the metabolism in diabetics].
    Pröls H; Haslbeck M
    Ther Ggw; 1974 Jul; 113(7):1194-6, 199-200, 202 passim. PubMed ID: 4612854
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacokinetics of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191) in man].
    Hinze HJ
    Arzneimittelforschung; 1972 Sep; 22(9):1492-5. PubMed ID: 4678611
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison between the absorption of nicotinic acid and pentaerythritol tetranicotinate (Perycit) from ordinary and enterocoated tablets.
    Svedmyr N; Harthon L
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):66-74. PubMed ID: 5467756
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative absorption profiles of divalproex sodium delayed-release versus extended-release tablets -- clinical implications.
    Dutta S; Reed RC; O'Dea RF
    Ann Pharmacother; 2006 Apr; 40(4):619-25. PubMed ID: 16569797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the circulation promoting treatment in parkinsonism].
    Völler G
    Hippokrates; 1969 May; 40(10):393-7. PubMed ID: 5803728
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical evaluation of xanthinol nicotinate ("complamin") in Nigerians with cerebral thrombosis.
    Dada TO
    West Afr Med J Niger Pract; 1971 Feb; 20(1):202-5. PubMed ID: 4930360
    [No Abstract]   [Full Text] [Related]  

  • 12. Cosaldon for vascular disorders?
    Drug Ther Bull; 1972 Aug; 10(17):66-8. PubMed ID: 4570865
    [No Abstract]   [Full Text] [Related]  

  • 13. [Variations in fibrinolytic activity and fibrinogen caused by xanthinol nicotinate in cases of diabetes mellitus with peripheral vascular lesions].
    Ipbüker A; Bayer H
    Turk Tip Cemiy Mecm; 1969 Apr; 35(4):236-46. PubMed ID: 5810400
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism of niflumic acid-14C: absorption, excretion and biotransformation by human and dog.
    Lan SJ; Chando TJ; Weliky I; Schreiber EC
    J Pharmacol Exp Ther; 1973 Aug; 186(2):323-30. PubMed ID: 4719785
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of food on the absorption of alpha-tocopheryl nicotinate in beagle dogs and human volunteers.
    Hasegawa J; Tomono Y; Fujita T; Sugiyama K; Hamamura K
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):216-9. PubMed ID: 7251237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of sideropenic anemia by means of a preparation that gradually releases iron into the intestine].
    Piancino G; Brusa L; Padula F
    Minerva Med; 1972 Nov; 63(81):4422-7. PubMed ID: 4565685
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acid secretion and blood circulation of the gastric mucosa during xanthinol-nicotinate administration].
    Rösch W; Brater J; Classen M
    Med Klin; 1972 Dec; 67(52):1723-7. PubMed ID: 4649517
    [No Abstract]   [Full Text] [Related]  

  • 18. [Xanthinol nicotinate].
    van der Pol HJ
    Pharm Weekbl; 1966 Mar; 101(12):286-7. PubMed ID: 5934970
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of omeprazole with enteric-coated salicylate tablets.
    Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of erythritol-tetra-nicotinate on serum-cholesterol levels in man.
    Brox D; Selvaag O
    Acta Med Scand; 1967 Oct; 182(4):437-44. PubMed ID: 6054827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.